MedPath
HSA Approval

METOCLOPRAMIDE SYRUP 5 mg/5 ml

SIN03349P

METOCLOPRAMIDE SYRUP 5 mg/5 ml

METOCLOPRAMIDE SYRUP 5 mg/5 ml

June 16, 1989

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

A03FA01

metoclopramide

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL SDN BHD

Active Ingredients

METOCLOPRAMIDE HCl EQV ANHYDROUS METOCLOPRAMIDE HCl

5 mg/5 ml

Metoclopramide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.